カテゴリー： 世界, 医療/バイオ, LP Information

世界の髄膜炎菌性髄膜炎用治療市場予測 2023年-2029年

【英語タイトル】Global Meningococcal Meningitis Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC05499）・商品コード：LP23DC05499
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の髄膜炎菌性髄膜炎用治療市場」は、過去の販売実績から2022年の世界の髄膜炎菌性髄膜炎用治療の総販売量を検討し、2023年から2029年の予測される髄膜炎菌性髄膜炎用治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の髄膜炎菌性髄膜炎用治療の市場規模を掲載し、XXX百万米ドル規模の世界の髄膜炎菌性髄膜炎用治療市場の詳細な分析を提供します。本インサイトレポートは、世界の髄膜炎菌性髄膜炎用治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の髄膜炎菌性髄膜炎用治療市場における各社の独自のポジションをより深く理解するために、髄膜炎菌性髄膜炎用治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の髄膜炎菌性髄膜炎用治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。髄膜炎菌性髄膜炎用治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。髄膜炎菌性髄膜炎用治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。髄膜炎菌性髄膜炎用治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

髄膜炎菌性髄膜炎用治療の世界主要メーカーとしては、Biomed Pvt. Ltd、 Novartis、 Nuron Biotech、 Pfizer、 Baxter、 Merck & Co.、 Sanofi、 GlaxoSmithKline Plc.、 F. Hoffmann-La Roche Ltd.、 Athlone Laboratories、 Wockhardt Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の髄膜炎菌性髄膜炎用治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では髄膜炎菌性髄膜炎用治療市場をセグメンテーションし、種類別 (経口、注射)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：経口、注射

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の髄膜炎菌性髄膜炎用治療市場の10年間の市場状況・展望は？
・世界および地域別に見た髄膜炎菌性髄膜炎用治療市場成長の要因は何か？
・髄膜炎菌性髄膜炎用治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・髄膜炎菌性髄膜炎用治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：髄膜炎菌性髄膜炎用治療の年間販売量2018-2029、地域別現状・将来分析
・髄膜炎菌性髄膜炎用治療の種類別セグメント：経口、注射
・髄膜炎菌性髄膜炎用治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・髄膜炎菌性髄膜炎用治療の用途別セグメント：病院薬局、小売薬局、オンライン薬局
・髄膜炎菌性髄膜炎用治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の髄膜炎菌性髄膜炎用治療市場
・企業別のグローバル髄膜炎菌性髄膜炎用治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の髄膜炎菌性髄膜炎用治療の年間売上：2018-2023年の売上、市場シェア
・企業別の髄膜炎菌性髄膜炎用治療販売価格
・主要企業の髄膜炎菌性髄膜炎用治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

髄膜炎菌性髄膜炎用治療の地域別レビュー
・地域別の髄膜炎菌性髄膜炎用治療市場規模2018-2023：年間販売量、売上
・主要国別の髄膜炎菌性髄膜炎用治療市場規模2018-2023：年間販売量、売上
・南北アメリカの髄膜炎菌性髄膜炎用治療販売の成長
・アジア太平洋の髄膜炎菌性髄膜炎用治療販売の成長
・ヨーロッパの髄膜炎菌性髄膜炎用治療販売の成長
・中東・アフリカの髄膜炎菌性髄膜炎用治療販売の成長

南北アメリカ市場
・南北アメリカの国別の髄膜炎菌性髄膜炎用治療販売量、売上（2018-2023）
・南北アメリカの髄膜炎菌性髄膜炎用治療の種類別販売量
・南北アメリカの髄膜炎菌性髄膜炎用治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の髄膜炎菌性髄膜炎用治療販売量、売上（2018-2023）
・アジア太平洋の髄膜炎菌性髄膜炎用治療の種類別販売量
・アジア太平洋の髄膜炎菌性髄膜炎用治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の髄膜炎菌性髄膜炎用治療販売量、売上（2018-2023）
・ヨーロッパの髄膜炎菌性髄膜炎用治療の種類別販売量
・ヨーロッパの髄膜炎菌性髄膜炎用治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の髄膜炎菌性髄膜炎用治療販売量、売上（2018-2023）
・中東・アフリカの髄膜炎菌性髄膜炎用治療の種類別販売量
・中東・アフリカの髄膜炎菌性髄膜炎用治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・髄膜炎菌性髄膜炎用治療の製造コスト構造分析
・髄膜炎菌性髄膜炎用治療の製造プロセス分析
・髄膜炎菌性髄膜炎用治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・髄膜炎菌性髄膜炎用治療の主要なグローバル販売業者
・髄膜炎菌性髄膜炎用治療の主要なグローバル顧客

地域別の髄膜炎菌性髄膜炎用治療市場予測レビュー
・地域別の髄膜炎菌性髄膜炎用治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・髄膜炎菌性髄膜炎用治療の種類別市場規模予測
・髄膜炎菌性髄膜炎用治療の用途別市場規模予測

主要企業分析
Biomed Pvt. Ltd、 Novartis、 Nuron Biotech、 Pfizer、 Baxter、 Merck & Co.、 Sanofi、 GlaxoSmithKline Plc.、 F. Hoffmann-La Roche Ltd.、 Athlone Laboratories、 Wockhardt Ltd.
・企業情報
・髄膜炎菌性髄膜炎用治療製品
・髄膜炎菌性髄膜炎用治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Meningococcal Meningitis Treatment market size is projected to grow from US$ 167 million in 2022 to US$ 233 million in 2029; it is expected to grow at a CAGR of 4.9% from 2023 to 2029.
United States market for Meningococcal Meningitis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Meningococcal Meningitis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Meningococcal Meningitis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Meningococcal Meningitis Treatment players cover Biomed Pvt. Ltd, Novartis, Nuron Biotech, Pfizer, Baxter, Merck & Co., Sanofi, GlaxoSmithKline Plc. and F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Meningococcal meningitis is a serious bacterial infection that causes inflammation of the protective membranes that cover the brain and spinal cord. The treatment of meningococcal meningitis typically involves antibiotics, supportive care, and vaccination.
LPI (LP Information)’ newest research report, the “Meningococcal Meningitis Treatment Industry Forecast” looks at past sales and reviews total world Meningococcal Meningitis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Meningococcal Meningitis Treatment sales for 2023 through 2029. With Meningococcal Meningitis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningococcal Meningitis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Meningococcal Meningitis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Meningococcal Meningitis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meningococcal Meningitis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningococcal Meningitis Treatment and breaks down the forecast by route, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningococcal Meningitis Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Meningitis Treatment market by product route, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by route
Oral
Injectable
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Biomed Pvt. Ltd
Novartis
Nuron Biotech
Pfizer
Baxter
Merck & Co.
Sanofi
GlaxoSmithKline Plc.
F. Hoffmann-La Roche Ltd.
Athlone Laboratories
Wockhardt Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Meningococcal Meningitis Treatment market?
What factors are driving Meningococcal Meningitis Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Meningococcal Meningitis Treatment market opportunities vary by end market size?
How does Meningococcal Meningitis Treatment break out route, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Meningococcal Meningitis Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Meningococcal Meningitis Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Meningococcal Meningitis Treatment by Country/Region, 2018, 2022 & 2029
2.2 Meningococcal Meningitis Treatment Segment by Route
2.2.1 Oral
2.2.2 Injectable
2.3 Meningococcal Meningitis Treatment Sales by Route
2.3.1 Global Meningococcal Meningitis Treatment Sales Market Share by Route (2018-2023)
2.3.2 Global Meningococcal Meningitis Treatment Revenue and Market Share by Route (2018-2023)
2.3.3 Global Meningococcal Meningitis Treatment Sale Price by Route (2018-2023)
2.4 Meningococcal Meningitis Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Meningococcal Meningitis Treatment Sales by Application
2.5.1 Global Meningococcal Meningitis Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Meningococcal Meningitis Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Meningococcal Meningitis Treatment Sale Price by Application (2018-2023)
3 Global Meningococcal Meningitis Treatment by Company
3.1 Global Meningococcal Meningitis Treatment Breakdown Data by Company
3.1.1 Global Meningococcal Meningitis Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Meningococcal Meningitis Treatment Sales Market Share by Company (2018-2023)
3.2 Global Meningococcal Meningitis Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Meningococcal Meningitis Treatment Revenue by Company (2018-2023)
3.2.2 Global Meningococcal Meningitis Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Meningococcal Meningitis Treatment Sale Price by Company
3.4 Key Manufacturers Meningococcal Meningitis Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Meningococcal Meningitis Treatment Product Location Distribution
3.4.2 Players Meningococcal Meningitis Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Meningococcal Meningitis Treatment by Geographic Region
4.1 World Historic Meningococcal Meningitis Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Meningococcal Meningitis Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Meningococcal Meningitis Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Meningococcal Meningitis Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Meningococcal Meningitis Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Meningococcal Meningitis Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Meningococcal Meningitis Treatment Sales Growth
4.4 APAC Meningococcal Meningitis Treatment Sales Growth
4.5 Europe Meningococcal Meningitis Treatment Sales Growth
4.6 Middle East & Africa Meningococcal Meningitis Treatment Sales Growth
5 Americas
5.1 Americas Meningococcal Meningitis Treatment Sales by Country
5.1.1 Americas Meningococcal Meningitis Treatment Sales by Country (2018-2023)
5.1.2 Americas Meningococcal Meningitis Treatment Revenue by Country (2018-2023)
5.2 Americas Meningococcal Meningitis Treatment Sales by Route
5.3 Americas Meningococcal Meningitis Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Meningococcal Meningitis Treatment Sales by Region
6.1.1 APAC Meningococcal Meningitis Treatment Sales by Region (2018-2023)
6.1.2 APAC Meningococcal Meningitis Treatment Revenue by Region (2018-2023)
6.2 APAC Meningococcal Meningitis Treatment Sales by Route
6.3 APAC Meningococcal Meningitis Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Meningococcal Meningitis Treatment by Country
7.1.1 Europe Meningococcal Meningitis Treatment Sales by Country (2018-2023)
7.1.2 Europe Meningococcal Meningitis Treatment Revenue by Country (2018-2023)
7.2 Europe Meningococcal Meningitis Treatment Sales by Route
7.3 Europe Meningococcal Meningitis Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Meningococcal Meningitis Treatment by Country
8.1.1 Middle East & Africa Meningococcal Meningitis Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Meningococcal Meningitis Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Meningococcal Meningitis Treatment Sales by Route
8.3 Middle East & Africa Meningococcal Meningitis Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Meningococcal Meningitis Treatment
10.3 Manufacturing Process Analysis of Meningococcal Meningitis Treatment
10.4 Industry Chain Structure of Meningococcal Meningitis Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Meningococcal Meningitis Treatment Distributors
11.3 Meningococcal Meningitis Treatment Customer
12 World Forecast Review for Meningococcal Meningitis Treatment by Geographic Region
12.1 Global Meningococcal Meningitis Treatment Market Size Forecast by Region
12.1.1 Global Meningococcal Meningitis Treatment Forecast by Region (2024-2029)
12.1.2 Global Meningococcal Meningitis Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Meningococcal Meningitis Treatment Forecast by Route
12.7 Global Meningococcal Meningitis Treatment Forecast by Application
13 Key Players Analysis
13.1 Biomed Pvt. Ltd
13.1.1 Biomed Pvt. Ltd Company Information
13.1.2 Biomed Pvt. Ltd Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.1.3 Biomed Pvt. Ltd Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Biomed Pvt. Ltd Main Business Overview
13.1.5 Biomed Pvt. Ltd Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.2.3 Novartis Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Nuron Biotech
13.3.1 Nuron Biotech Company Information
13.3.2 Nuron Biotech Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.3.3 Nuron Biotech Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Nuron Biotech Main Business Overview
13.3.5 Nuron Biotech Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.4.3 Pfizer Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Baxter
13.5.1 Baxter Company Information
13.5.2 Baxter Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.5.3 Baxter Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Baxter Main Business Overview
13.5.5 Baxter Latest Developments
13.6 Merck & Co.
13.6.1 Merck & Co. Company Information
13.6.2 Merck & Co. Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.6.3 Merck & Co. Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Merck & Co. Main Business Overview
13.6.5 Merck & Co. Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.7.3 Sanofi Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 GlaxoSmithKline Plc.
13.8.1 GlaxoSmithKline Plc. Company Information
13.8.2 GlaxoSmithKline Plc. Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.8.3 GlaxoSmithKline Plc. Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GlaxoSmithKline Plc. Main Business Overview
13.8.5 GlaxoSmithKline Plc. Latest Developments
13.9 F. Hoffmann-La Roche Ltd.
13.9.1 F. Hoffmann-La Roche Ltd. Company Information
13.9.2 F. Hoffmann-La Roche Ltd. Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.9.3 F. Hoffmann-La Roche Ltd. Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.9.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.10 Athlone Laboratories
13.10.1 Athlone Laboratories Company Information
13.10.2 Athlone Laboratories Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.10.3 Athlone Laboratories Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Athlone Laboratories Main Business Overview
13.10.5 Athlone Laboratories Latest Developments
13.11 Wockhardt Ltd.
13.11.1 Wockhardt Ltd. Company Information
13.11.2 Wockhardt Ltd. Meningococcal Meningitis Treatment Product Portfolios and Specifications
13.11.3 Wockhardt Ltd. Meningococcal Meningitis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Wockhardt Ltd. Main Business Overview
13.11.5 Wockhardt Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Meningococcal Meningitis Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Meningococcal Meningitis Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Global Meningococcal Meningitis Treatment Sales by Route (2018-2023) & (K Units)
Table 6. Global Meningococcal Meningitis Treatment Sales Market Share by Route (2018-2023)
Table 7. Global Meningococcal Meningitis Treatment Revenue by Route (2018-2023) & ($ million)
Table 8. Global Meningococcal Meningitis Treatment Revenue Market Share by Route (2018-2023)
Table 9. Global Meningococcal Meningitis Treatment Sale Price by Route (2018-2023) & (US$/Unit)
Table 10. Global Meningococcal Meningitis Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Meningococcal Meningitis Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Meningococcal Meningitis Treatment Revenue by Application (2018-2023)
Table 13. Global Meningococcal Meningitis Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Meningococcal Meningitis Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Meningococcal Meningitis Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Meningococcal Meningitis Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Meningococcal Meningitis Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Meningococcal Meningitis Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Meningococcal Meningitis Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Meningococcal Meningitis Treatment Producing Area Distribution and Sales Area
Table 21. Players Meningococcal Meningitis Treatment Products Offered
Table 22. Meningococcal Meningitis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Meningococcal Meningitis Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Meningococcal Meningitis Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Meningococcal Meningitis Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Meningococcal Meningitis Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Meningococcal Meningitis Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Meningococcal Meningitis Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Meningococcal Meningitis Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Meningococcal Meningitis Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Meningococcal Meningitis Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Meningococcal Meningitis Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Meningococcal Meningitis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Meningococcal Meningitis Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Meningococcal Meningitis Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Meningococcal Meningitis Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Meningococcal Meningitis Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Meningococcal Meningitis Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Meningococcal Meningitis Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Meningococcal Meningitis Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Meningococcal Meningitis Treatment Sales by Route (2018-2023) & (K Units)
Table 44. APAC Meningococcal Meningitis Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Meningococcal Meningitis Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Meningococcal Meningitis Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Meningococcal Meningitis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Meningococcal Meningitis Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Meningococcal Meningitis Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Meningococcal Meningitis Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Meningococcal Meningitis Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Meningococcal Meningitis Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Meningococcal Meningitis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Meningococcal Meningitis Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Meningococcal Meningitis Treatment Sales by Route (2018-2023) & (K Units)
Table 56. Middle East & Africa Meningococcal Meningitis Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Meningococcal Meningitis Treatment
Table 58. Key Market Challenges & Risks of Meningococcal Meningitis Treatment
Table 59. Key Industry Trends of Meningococcal Meningitis Treatment
Table 60. Meningococcal Meningitis Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Meningococcal Meningitis Treatment Distributors List
Table 63. Meningococcal Meningitis Treatment Customer List
Table 64. Global Meningococcal Meningitis Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Meningococcal Meningitis Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Meningococcal Meningitis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Meningococcal Meningitis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Meningococcal Meningitis Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Meningococcal Meningitis Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Meningococcal Meningitis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Meningococcal Meningitis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Meningococcal Meningitis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Meningococcal Meningitis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Meningococcal Meningitis Treatment Sales Forecast by Route (2024-2029) & (K Units)
Table 75. Global Meningococcal Meningitis Treatment Revenue Forecast by Route (2024-2029) & ($ Millions)
Table 76. Global Meningococcal Meningitis Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Meningococcal Meningitis Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Biomed Pvt. Ltd Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Biomed Pvt. Ltd Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 80. Biomed Pvt. Ltd Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Biomed Pvt. Ltd Main Business
Table 82. Biomed Pvt. Ltd Latest Developments
Table 83. Novartis Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 85. Novartis Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Novartis Main Business
Table 87. Novartis Latest Developments
Table 88. Nuron Biotech Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Nuron Biotech Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 90. Nuron Biotech Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Nuron Biotech Main Business
Table 92. Nuron Biotech Latest Developments
Table 93. Pfizer Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 95. Pfizer Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Baxter Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Baxter Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 100. Baxter Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Baxter Main Business
Table 102. Baxter Latest Developments
Table 103. Merck & Co. Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck & Co. Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 105. Merck & Co. Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Merck & Co. Main Business
Table 107. Merck & Co. Latest Developments
Table 108. Sanofi Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 110. Sanofi Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. GlaxoSmithKline Plc. Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline Plc. Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 115. GlaxoSmithKline Plc. Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. GlaxoSmithKline Plc. Main Business
Table 117. GlaxoSmithKline Plc. Latest Developments
Table 118. F. Hoffmann-La Roche Ltd. Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. F. Hoffmann-La Roche Ltd. Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 120. F. Hoffmann-La Roche Ltd. Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. F. Hoffmann-La Roche Ltd. Main Business
Table 122. F. Hoffmann-La Roche Ltd. Latest Developments
Table 123. Athlone Laboratories Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Athlone Laboratories Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 125. Athlone Laboratories Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Athlone Laboratories Main Business
Table 127. Athlone Laboratories Latest Developments
Table 128. Wockhardt Ltd. Basic Information, Meningococcal Meningitis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Wockhardt Ltd. Meningococcal Meningitis Treatment Product Portfolios and Specifications
Table 130. Wockhardt Ltd. Meningococcal Meningitis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Wockhardt Ltd. Main Business
Table 132. Wockhardt Ltd. Latest Developments
List of Figures
Figure 1. Picture of Meningococcal Meningitis Treatment
Figure 2. Meningococcal Meningitis Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Meningococcal Meningitis Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Meningococcal Meningitis Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Meningococcal Meningitis Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injectable
Figure 11. Global Meningococcal Meningitis Treatment Sales Market Share by Route in 2022
Figure 12. Global Meningococcal Meningitis Treatment Revenue Market Share by Route (2018-2023)
Figure 13. Meningococcal Meningitis Treatment Consumed in Hospital Pharmacy
Figure 14. Global Meningococcal Meningitis Treatment Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 15. Meningococcal Meningitis Treatment Consumed in Retail Pharmacy
Figure 16. Global Meningococcal Meningitis Treatment Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 17. Meningococcal Meningitis Treatment Consumed in Online Pharmacy
Figure 18. Global Meningococcal Meningitis Treatment Market: Online Pharmacy (2018-2023) & (K Units)
Figure 19. Global Meningococcal Meningitis Treatment Sales Market Share by Application (2022)
Figure 20. Global Meningococcal Meningitis Treatment Revenue Market Share by Application in 2022
Figure 21. Meningococcal Meningitis Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Meningococcal Meningitis Treatment Sales Market Share by Company in 2022
Figure 23. Meningococcal Meningitis Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Meningococcal Meningitis Treatment Revenue Market Share by Company in 2022
Figure 25. Global Meningococcal Meningitis Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Meningococcal Meningitis Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Meningococcal Meningitis Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Meningococcal Meningitis Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Meningococcal Meningitis Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Meningococcal Meningitis Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Meningococcal Meningitis Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Meningococcal Meningitis Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Meningococcal Meningitis Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Meningococcal Meningitis Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Meningococcal Meningitis Treatment Sales Market Share by Country in 2022
Figure 36. Americas Meningococcal Meningitis Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Meningococcal Meningitis Treatment Sales Market Share by Route (2018-2023)
Figure 38. Americas Meningococcal Meningitis Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Meningococcal Meningitis Treatment Sales Market Share by Region in 2022
Figure 44. APAC Meningococcal Meningitis Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Meningococcal Meningitis Treatment Sales Market Share by Route (2018-2023)
Figure 46. APAC Meningococcal Meningitis Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Meningococcal Meningitis Treatment Sales Market Share by Country in 2022
Figure 55. Europe Meningococcal Meningitis Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Meningococcal Meningitis Treatment Sales Market Share by Route (2018-2023)
Figure 57. Europe Meningococcal Meningitis Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Meningococcal Meningitis Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Meningococcal Meningitis Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Meningococcal Meningitis Treatment Sales Market Share by Route (2018-2023)
Figure 66. Middle East & Africa Meningococcal Meningitis Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Meningococcal Meningitis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Meningococcal Meningitis Treatment in 2022
Figure 73. Manufacturing Process Analysis of Meningococcal Meningitis Treatment
Figure 74. Industry Chain Structure of Meningococcal Meningitis Treatment
Figure 75. Channels of Distribution
Figure 76. Global Meningococcal Meningitis Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Meningococcal Meningitis Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Meningococcal Meningitis Treatment Sales Market Share Forecast by Route (2024-2029)
Figure 79. Global Meningococcal Meningitis Treatment Revenue Market Share Forecast by Route (2024-2029)
Figure 80. Global Meningococcal Meningitis Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Meningococcal Meningitis Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の髄膜炎菌性髄膜炎用治療市場予測 2023年-2029年] (コード：LP23DC05499)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の髄膜炎菌性髄膜炎用治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の髄膜炎用検出キット市場予測 2023年-2029年
  • 世界の多汗症治療用ボトックス市場予測 2023年-2029年
  • 世界の矯正治療用製品市場予測 2023年-2029年
  • 世界の静脈性潰瘍用治療市場予測 2023年-2029年
  • 世界のシュニッツラー症候群治療市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆